Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure
Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of Cardiac Sympathetic Blockade on
Mortality, re-hospitalization rate, symptoms, quality of life, exercise tolerance, cardiac
structure, systolic function, electrical activities and concentration of B - type natriuretic
peptide precursor in patients with Chronic Heart Failure.
Phase:
N/A
Details
Lead Sponsor:
First Affiliated Hospital of Harbin Medical University